Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Obstet Gynecol. 2022 Aug 3;140(3):477–487. doi: 10.1097/AOG.0000000000004896

Table 1.

Exposure Characteristics

Category Term Definition
Exposure Windows * Current Use Exposure within 28 days before the index date (primary analysis)
Recent Use Exposure within 84 days before the index date
Prior Use Exposure within 85 through 365 days before the index date
Non-current Use Cannot have any progestogen exposure within 28 days before the index date (reference for primary analysis)
Dose Weighted Average Daily Dose The cumulative prescribed dose within recent use averaged over the interval from start of exposure until the index date (maximum of 84 days)
Low Category Weighted average daily dose less than half the standard daily dose of each oral progestogen
Standard Category Weighted average daily dose between half to less than double the standard daily dose of each oral progestogen
High Category Weighted average daily dose greater than or equal to double the standard daily dose of each oral progestogen
Chronicity New Users All exposure occurs within no more than 84 days before the index date (i.e., no prior use) and meets current use criteria
Chronic Users Exposure meets both prior use and current use criteria
Former Users Exposure meets prior use but not current use criteria
Non-users Cannot have any progestogen exposure that meets criteria for current use or prior use (reference only for chronicity analysis)
*

Current, recent, and prior use definitions are not affected by progestogen exposure or absence of exposure outside of its time window (e.g., exposures may continue beyond the index date).